RMD vs XYL · P/E 29, rev $5.65B vs P/E 27, rev $4.46B
ResMed Inc (RMD) versus Xylem Inc (XYL) — a side-by-side from cached financials, not a winner call.
ResMed Inc (RMD) is a medical instruments & supplies company listed on US.
Xylem Inc (XYL) is a specialty industrial machinery company listed on NYSE.
Latest reported RMD revenue for 2026-06-30 was $5.65B. Net income was $1.52B. Revenue was up 9.9% from 2025-06-30 to 2026-06-30. RMD currently screens at market cap $37.68B and trailing P/E 28.8.
Latest reported XYL revenue for 2026-06-30 was $4.46B. Net income was $456.0M. XYL currently screens at market cap $26.22B and trailing P/E 27.4.
RMD currently screens at market cap $37.68B and trailing P/E 28.8. XYL currently screens at market cap $26.22B and trailing P/E 27.4.
Not investment advice. Open the RMD and XYL stock pages for the full models.
Not investment advice.